Short info
- 4624 VT Bergen op Zoom - Netherlands
- Dutch English
- Reg. Nr. 99048451101
- Reg. country: Netherlands
Walk-in consultation
Consultation fee:
EURThis doctor is currently available for a walk-in consultation.Please complete the form and click “Pay and Continue” to proceed.After your payment is confirmed, you’ll be placed in the waiting room. If others are ahead of you, a short wait may apply.
Register for the walk-in consultation with this doctor.
Don’t have an account yet? You can create one now. Prefer to continue without an account? That’s also possible. Please note: without an account, you will only have one-time access to the secure patient portal after your consultation to download any documents the doctor may share with you. With an account, you’ll have ongoing access and can also message the doctor after your appointment.
* required fields.
Email advice:
M Tjioe
Consultation fee:
EURReceive professional advice from this certified dermatologist by email within two working days
Step 1 from 3: Enter personal information
* required fields.
About me
Why choose Dr. Milan Tjioe?
Dr. Milan Tjioe is an experienced dermatologist known for his thorough and patient-focused care, combining clinical expertise with a strong research background. He has been practicing dermatology at Bravis Hospital Dermatology Department since 2009 and also works with dermaTeam clinics, bringing years of hands-on experience with a wide range of skin conditions. Patients value his deep understanding of both common and complex skin diseases and his commitment to evidence-based treatment strategies. As a BIG-registered physician (number 99048451101), he meets the Dutch quality and safety standards for dermatology and venereology care.
Specialism
Dr. Tjioe is a general dermatologist with particular expertise in chronic inflammatory skin disorders such as psoriasis, eczema, hidradenitis suppurativa, urticaria, vitiligo and alopecia areata. He also treats skin cancer and provides care for patients of all ages, including children. In addition to clinical work, he leads the dermaTeam Research department, where he has been principal investigator for numerous clinical trials evaluating new treatments for dermatological conditions. His combination of clinical practice and research helps ensure patients receive modern, effective therapies.
Education and career
Dr. Tjioe completed his medical degree and dermatology specialization at the University Medical Center St Radboud in Nijmegen, the Netherlands, and earned his PhD in 2003 after research on the harmful effects of ultraviolet (UV) radiation and improved phototherapy for vitiligo. He has contributed to dermatology literature, including works on vitiligo and inflammatory skin diseases. He has also been a leader in implementing online dermatology services, helping modernize patient access to care.
Schedule a consultation with this dermatologist at your convenience.
Working experience
Education
Publications
Granular cell tumor
Vitiligo en zo: antwoorden op de meest gestelde vragen met betrekking tot vitiligo
Remarkable success of Chinese herbs in combination with a short course of low-dose narrow-band UVB phototherapy in severe recalcitrant plaque psoriasis
Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12
Phototherapy: Photobiological aspects and therapeutical developments
Adalimumab, a fully human anti-TNF-alpha monoclonal antibody, treatment does not influence experimental UV response in the skin of rheumatoid arthritis patients.
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study
Understanding Comorbidities and Concomitant Medication Patterns in Patients With Moderate-to-Severe Plaque Psoriasis in the Real-World Psoriasis Study of Health Outcomes (PSoHO)
Real-world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch)
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry
Switching to Interleukin‑23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real‑World Outcomes in Psoriasis Treatment
Multi-treatment resistance to biological treatment in patients withpsoriasis: Definitions and implications
Psoriasis healthcare during the COVID-19 pandemic: a survey among psoriasis patients (PsoCovidCare)
